Atlas Trials

Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia Chronic Phase With Sustained MR4log

Clinical trial NCT03239886 · UNKNOWN

Trial details

NCT number
NCT03239886
Sponsor
University of Sao Paulo General Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Leukemia, Myeloid, Chronic-Phase
Start date
2016-12-15
Primary completion
2019-08-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.